-
1
-
-
0033561642
-
-
E. A. Ariazi, Y. Satomi, M. J. Ellis, J. D. Haag, W. Shi, C. A. Sattler, M. N. Gould, Cancer Res. 1999, 59, 1917;
-
(1999)
Cancer Res
, vol.59
, pp. 1917
-
-
Ariazi, E.A.1
Satomi, Y.2
Ellis, M.J.3
Haag, J.D.4
Shi, W.5
Sattler, C.A.6
Gould, M.N.7
-
3
-
-
0036870653
-
-
Y. D. Burke, A. S. Ayoubi, S. R. Werner, B. C. McFarland, D. K. Heilman, B. A. Ruggeri, P. L. Crowell, Anticancer Res. 2002, 22, 3127;
-
(2002)
Anticancer Res
, vol.22
, pp. 3127
-
-
Burke, Y.D.1
Ayoubi, A.S.2
Werner, S.R.3
McFarland, B.C.4
Heilman, D.K.5
Ruggeri, B.A.6
Crowell, P.L.7
-
4
-
-
0038308362
-
-
S. M. Meadows, D. Mulkerin, J. Berlin, H. Bailey, J. Kolesar, D. Warren, J. P. Thomas, Int. J. Gastrointest. Cancer 2002, 32, 125;
-
S. M. Meadows, D. Mulkerin, J. Berlin, H. Bailey, J. Kolesar, D. Warren, J. P. Thomas, Int. J. Gastrointest. Cancer 2002, 32, 125;
-
-
-
-
5
-
-
33847164134
-
-
D. A. Wiseman, S. R. Werner, P. L. Crowell, J. Pharmacol. Exp. Ther. 2006, 320, 1163.
-
(2006)
J. Pharmacol. Exp. Ther
, vol.320
, pp. 1163
-
-
Wiseman, D.A.1
Werner, S.R.2
Crowell, P.L.3
-
6
-
-
0345303681
-
-
Y. Kaminaga, A. Nagatsu, T. Akiyama, N. Sugimoto, T. Yamazaki, T. Maitani, H. Mizukami, FEBS Lett. 2003, 555, 311;
-
(2003)
FEBS Lett
, vol.555
, pp. 311
-
-
Kaminaga, Y.1
Nagatsu, A.2
Akiyama, T.3
Sugimoto, N.4
Yamazaki, T.5
Maitani, T.6
Mizukami, H.7
-
7
-
-
33644986684
-
-
Y. Kondo, K. Shimoda, J, Takimura, H. Hamada, H. Hamada, Chem. Lett. 2006, 35, 324;
-
(2006)
Chem. Lett
, vol.35
, pp. 324
-
-
Kondo, Y.1
Shimoda, K.2
Takimura, J.3
Hamada, H.4
Hamada, H.5
-
8
-
-
34248522558
-
-
K. Shimoda, Y. Kondo, M. Akagi, K. Abe, H. Hamada, H. Hamada, Chem. Lett. 2007, 36, 570;
-
(2007)
Chem. Lett
, vol.36
, pp. 570
-
-
Shimoda, K.1
Kondo, Y.2
Akagi, M.3
Abe, K.4
Hamada, H.5
Hamada, H.6
-
9
-
-
36048930192
-
-
K. Shimoda, T. Otsuka, Y. Morimoto, H. Hamada, H. Hamada, Chem. Lett. 2007, 36, 1292;
-
(2007)
Chem. Lett
, vol.36
, pp. 1292
-
-
Shimoda, K.1
Otsuka, T.2
Morimoto, Y.3
Hamada, H.4
Hamada, H.5
-
10
-
-
35349000608
-
-
K. Shimoda, Y. Kondo, M. Akagi, K. Abe, H. Hamada, H. Hamada, Phytochemistry 2007, 68, 2678.
-
(2007)
Phytochemistry
, vol.68
, pp. 2678
-
-
Shimoda, K.1
Kondo, Y.2
Akagi, M.3
Abe, K.4
Hamada, H.5
Hamada, H.6
-
11
-
-
0027651084
-
-
W. Guo, K. Sakata, N. Watanabe, R. Nakajima, A. Yagi, K. Ina, S. Luo, Phytochemistry 1993, 33, 1373;
-
(1993)
Phytochemistry
, vol.33
, pp. 1373
-
-
Guo, W.1
Sakata, K.2
Watanabe, N.3
Nakajima, R.4
Yagi, A.5
Ina, K.6
Luo, S.7
-
12
-
-
0028489368
-
-
W. Guo, R. Hosoi, K. Sakata, N. Watanabe, A. Yagi, K. Ina, S. Luo, Biosci. Biotechnol. Biochem. 1994, 58, 1532;
-
(1994)
Biosci. Biotechnol. Biochem
, vol.58
, pp. 1532
-
-
Guo, W.1
Hosoi, R.2
Sakata, K.3
Watanabe, N.4
Yagi, A.5
Ina, K.6
Luo, S.7
-
13
-
-
0030293127
-
-
J.-H. Moon, N. Watanabe, Y. Ijima, A. Yagi, K. Ina, K. Sakata, Biosci. Biotechnol. Biochem. 1996, 60, 1815;
-
(1996)
Biosci. Biotechnol. Biochem
, vol.60
, pp. 1815
-
-
Moon, J.-H.1
Watanabe, N.2
Ijima, Y.3
Yagi, A.4
Ina, K.5
Sakata, K.6
-
14
-
-
0029778968
-
-
M. Nishikitani, K. Kubota, A. Kobayashi, F. Sugawara, Biosci. Biotechnol. Biochem. 1996, 60, 929.
-
(1996)
Biosci. Biotechnol. Biochem
, vol.60
, pp. 929
-
-
Nishikitani, M.1
Kubota, K.2
Kobayashi, A.3
Sugawara, F.4
-
15
-
-
45449110094
-
-
Biotransformation of substrates with plant cell cultures was carried out as follows. Prior to this experiment, 100 g of cultured plant cells were individually transplanted to 1-L conical flasks containing 500 mL of Murashige and Skoog's medium (pH 5.7, The cells were grown for an additional 1 month on a rotary shaker (120 rpm) at 25 °C in the dark. Substrate (a total amount of 10 mmol) was administered to ten 1-L conical flasks (1 mmol/flask) containing the suspension cultured cells. After incubation of the cultures for 3 days on a rotary shaker (120 rpm, the cells and medium were separated by filtration with suction. The cells were homogenized (×3) with MeOH. The MeOH-extract was concentrated, and the residue was partitioned between H2O and EtOAc. The H2O layer was applied to a Diaion HP-20 column and the column was washed with H2O followed by elution with MeOH. The MeOH eluate was subjected to HPLC [column: YMC-Pack R&D ODS column 150
-
2O (3:7, v/v); detection: UV (280 nm); flow rate: 1.0mL/min] to give products.
-
-
-
-
16
-
-
45449109675
-
-
Spectral data for new compounds; product 4: HRFABMS: m/z 407.2411 [M+ Na, 1HNMR (400 MHz, CD3OD, δ; 1.61 (6H, s, H-13, 14, 1.67 (3H, s, H-12, 1.69 (3H, s, H-15, 2.05 (4H, m, H-8, 9, 2.11 (4H, m, H-4, 5, 3.16-3.36 (4H, m, H-2′, 3′, 4′, 5′, 3.67 (1H, dd, J, 12.0, 5.6Hz, H-6a, 3.86 (1H, dd, J= 12.4, 2.4Hz, H-6b, 4.23 (1H, d, J, 8.0Hz, H-1a, 4.28 (1H, d, J, 8.0Hz, H-1′, 4.34 (1H, d, J, 8.0Hz, H-1b, 5.10 (2H, t, J, 7.0Hz, H-6, 10, 5.37 (1H, t, J, 7.0Hz, H-2, 13CNMR (100 MHz, CD3OD, δ 16.5 (C-14, 17.8 (C-15, 25.9 (C-12, 27.4 (C-5, 27.8 (C-9, 40.8 (C-4, 41.0 (C-8, 62.8 (C-6′, 66.3 (C-4′, 71.7 (C-2′, 75.0 (C-5′, 77.9 (C-3′, 102.7 (C-1′, 121.5 (C-2, 125.0 (C-6, C-10, 132.4 (C-7, C-11, 141.7 (C-3, Product 5: HRFABMS: m/z 339.1790 [M, Na, 1HNMR CD3
-
3OD): δ 20.9 (C-10), 27.5 (C-6), 28.8 (C-5), 31.7 (C-3), 42.5 (C-4), 62.2 (C-6″, C-6‴), 62.7 (C-6′ 71.5 (C-4‴), 73.3 (C-5″), 73.8 (C-2″), 74.2 (C-2‴), 74.5 (C-7), 74.7 (C-3‴, C-5‴), 74.9 (C-2′75.1 (C-3″), 76.5 (C-5′77.8 (C-3′), 81.3 (C-4′, C-4″). 102.6 (C-1‴), 102.8 (C-1′, C-1″), 109.1 (C-9), 125.9 (C-2), 135.4 (C-1), 150.9 (C-8).
-
-
-
-
17
-
-
45449110095
-
-
Glycosylation with CGTase was carried out as follows. To a solution containing 10 mL of 25 mM sodium phosphate buffer (pH 7.0), 0.5 mmol of perillyl β-D-glucoside (6), and 5 g of soluble starch was added 300 units of CGTase from Bacillus macerans. After incubation of the mixture for 24 h at 40°C, the mixture was centrifuged at 3000 g for 10 min. The supernatant was subjected to Sephadex G-25 column chromatography. The glycoside fractions were lyophilized and purified by preparative HPLC to give products.
-
Glycosylation with CGTase was carried out as follows. To a solution containing 10 mL of 25 mM sodium phosphate buffer (pH 7.0), 0.5 mmol of perillyl β-D-glucoside (6), and 5 g of soluble starch was added 300 units of CGTase from Bacillus macerans. After incubation of the mixture for 24 h at 40°C, the mixture was centrifuged at 3000 g for 10 min. The supernatant was subjected to Sephadex G-25 column chromatography. The glycoside fractions were lyophilized and purified by preparative HPLC to give products.
-
-
-
|